Raymond Chang is a highly accomplished Translational Imaging Scientist with over two decades of expertise spanning pharmaceutical research, contract research organizations (CROs), and academic discovery. With a robust foundation in both preclinical and clinical settings, Raymond has demonstrated a unique ability to bridge cutting-edge imaging technologies with therapeutic development, enhancing patient care and advancing the frontier of personalized medicine.
Raymond’s multifaceted career is marked by proficiency across diverse imaging modalities, including PET, SPECT, and CT, alongside an expansive portfolio of preclinical disease models. His expertise encompasses cardiovascular and pulmonary research, immuno-PET, in vivo pharmacology, and neuroimaging, contributing to breakthrough innovations in imaging-based toxicology and nuclear medicine research.
As a senior leader at United Imaging Healthcare America, Raymond spearheads clinical and non-clinical investigations, leveraging imaging technologies to optimize drug development and regulatory compliance. His prior roles at Charles River Laboratories and Regeneron Pharmaceuticals underscore his strategic leadership in GLP and Non-GLP studies, driving the evaluation of drug candidates and medical devices while refining imaging protocols and bioinformatics platforms.
A testament to his pioneering contributions, Raymond received the 2006 Young Investigator Award for his groundbreaking work on GABAB-mediated metabolic processes. He later earned the 2018 Research Associate Award for introducing the enterprise implementation of IPACS, a multimodality bioinformatics system that transformed research workflows. His inventive prowess also led to the development of the first semi-automated imaging segmentation tool for small animal echocardiograms.
In academic settings, Raymond has played an instrumental role in establishing premier imaging facilities, such as implementing the Siemens Inveon PET/CT site at the Medical University of South Carolina and installing the micro-MRI system at the University of Louisville Preclinical Imaging Core.
Beyond his technical acumen, Raymond is a proven project manager and collaborator, adept at IACUC/IRB submissions, FDA regulatory processes, and client services within CRO frameworks. His leadership extends to mentoring research teams, training personnel, and fostering partnerships across institutions.
Raymond’s educational background, including an MSc in Behavioral Neuroscience and dual MA and BA degrees in Clinical and Experimental Psychology, laid the groundwork for his innovative approach to imaging science. His professional affiliations with organizations such as the Society of Nuclear Medicine and the World Molecular Imaging Congress reflect his commitment to advancing the field.
With a career distinguished by scientific rigor, technical innovation, and strategic leadership, Raymond continues to shape the landscape of translational imaging, driving discoveries that bridge science and clinical application.
Character
Raymond Chang is a dedicated and results-driven leader with a strong work ethic and an unwavering commitment to advancing translational imaging science for improved patient care.
Knowledge
With over 20 years of experience, Dr. Chang possesses extensive expertise in diverse imaging modalities, preclinical disease models, and regulatory compliance within pharmaceutical, academic, and CRO settings.
Strategic
Dr. Chang demonstrates exceptional strategic acumen by implementing innovative imaging solutions, streamlining research processes, and driving the successful execution of preclinical and clinical studies.
Communication
A skilled communicator and collaborator, Dr. Chang effectively engages with multidisciplinary teams, regulatory bodies, and clients to facilitate research goals and foster long-term partnerships.
